Commentary
New players in non-alcoholic fatty liver disease induced carcinogenesis: lipid dysregulation impairs liver immune surveillance
Abstract
Hepatocellular carcinoma (HCC), the primary cancer of the liver, is the fifth most common cancer and the second most common cause of cancer-related death worldwide with an expectancy to increase its incidence over the next 10–20 years (1).